Synergistic and antagonistic interactions between bednets and vaccines in the control of malaria

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 10, 2015, Pages 3014-3019

  Artzy Randrup, Yael ^a,b   Dobson, Andrew P ^c,d   Pascual, Mercedes ^a,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c PRINCETON UNIVERSITY   (United States)

^d SANTA FE INSTITUTE   (United States)

Author keywords

Combined intervention; Malaria control; Malaria eradication; Treated bednets; Vaccines

Indexed keywords

MALARIA VACCINE;

ADAPTIVE IMMUNITY; ARTICLE; BASIC REPRODUCTION NUMBER; BED NET; DISEASE TRANSMISSION; DRUG POTENTIATION; HOST; HUMAN; MALARIA; MALARIA CONTROL; MATHEMATICAL MODEL; PATHOGEN CLEARANCE; PRIORITY JOURNAL; REVACCINATION; VACCINATION; TRANSMISSION;

BANANA STREAK VIRUS; TULIP BREAKING VIRUS;

HUMANS; MALARIA; MALARIA VACCINES; MOSQUITO NETS;

EID: 84924302026     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1409467112     Document Type: Article

References (75)

1. World Health Organization (WHO) (2013) World Malaria Report 2013 (WHO, Geneva).
2. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434(7030):214-217.
3. World Health Organization (WHO) (2013) Tables of malaria vaccine projects globally: The rainbow tables. Available at www.who.int/immunization/research/development/Rainbow-tables/en/.
4. Agnandji ST, et al.; RTS,S Clinical Trials Partnership (2012) A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med 367(24):2284-2295.
5. Olotu A, et al. (2013) Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. N Engl J Med 368(12):1111-1120.
6. Moorthy VS, Newman RD, Okwo-Bele JM (2013) Malaria vaccine technology roadmap. Lancet 382(9906):1700-1701.
7. Hill AV (2011) Vaccines against malaria. Philos Trans R Soc Lond B Biol Sci 366(1579):2806-2814.
8. Stanisic DI, Barry AE, Good MF (2013) Escaping the immune system: How the malaria parasite makes vaccine development a challenge. Trends Parasitol 29(12):612-622.
9. Crompton PD, Pierce SK, Miller LH (2010) Advances and challenges in malaria vaccine development. J Clin Invest 120(12):4168-4178.
10. Snow RW, et al. (1997) Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 349(9066):1650-1654.
11. Gupta S, Snow RW, Donnelly C, Newbold C (1999) Acquired immunity and postnatal clinical protection in childhood cerebral malaria. Proc Biol Sci 266(1414):33-38.
12. World Health Organization (WHO) (2007) Insecticide Treated Mosquito Nets: A WHO Position Statement (WHO, Geneva).
13. Lim SS, et al. (2011) Net benefits: A multicountry analysis of observational data examining associations between insecticide-treated mosquito nets and health outcomes. PLoS Med 8(9):e1001091.
14. Eisele TP, et al. (2012) Estimates of child deaths prevented from malaria prevention scale-up in Africa 2001-2010. Malar J 11:93.
15. Fine PE (1993) Herd immunity: History, theory, practice. Epidemiol Rev 15(2):265-302.
16. Anderson RM, May RM (1985) Vaccination and herd immunity to infectious diseases. Nature 318(6044):323-329.
17. Dobson A (2009) Climate variability, global change, immunity, and the dynamics of infectious diseases. Ecology 90(4):920-927.
18. Killeen GF, et al. (2007) Preventing childhood malaria in Africa by protecting adults from mosquitoes with insecticide-treated nets. PLoS Med 4(7):e229.
19. Shaukat AM, Breman JG, McKenzie FE (2010) Using the entomological inoculation rate to assess the impact of vector control on malaria parasite transmission and elimination. Malar J 9:122.
20. Griffin JT, et al. (2010) Reducing Plasmodium falciparum malaria transmission in Africa: A model-based evaluation of intervention strategies. PLoS medicine 7(8):e1000324.
21. Karunamoorthi K (2011) Vector control: A cornerstone in the malaria elimination campaign. Clin Microbiol Infect 17(11):1608-1616.
22. Chambers RG (2012) UN Envoy's response to estimates of global malaria mortality. Lancet 379(9817):707-708.
23. Tirados I, Costantini C, Gibson G, Torr SJ (2006) Blood-feeding behaviour of the malarial mosquito Anopheles arabiensis: Implications for vector control. Med Vet Entomol 20(4):425-437.
24. Pates H, Curtis C (2005) Mosquito behavior and vector control. Annu Rev Entomol 50:53-70.
25. Trung HD, et al. (2005) Behavioural heterogeneity of Anopheles species in ecologically different localities in Southeast Asia: A challenge for vector control. Trop Med Int Health 10(3):251-262.
26. Durnez L, et al. (2013) Outdoor malaria transmission in forested villages of Cambodia. Malar J 12:329.
27. Riley EM, Stewart VA (2013) Immune mechanisms in malaria: New insights in vaccine development. Nat Med 19(2):168-178.
28. DeWeerdt S (2012) Vaccines: The take-home lesson. Nature 484(7395):S24-S25.
29. Carter R, Mendis KN, Miller LH, Molineaux L, Saul A (2000) Malaria transmission-blocking vaccines - how can their development be supported? Nat Med 6(3):241-244.
30. Dinglasan RR, Jacobs-Lorena M (2008) Flipping the paradigm on malaria transmission-blocking vaccines. Trends Parasitol 24(8):364-370.
31. Owusu-Agyei S, et al. (2001) Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana. Am J Trop Med Hyg 65(3):197-203.
32. Shiff C (1997) A call for integrated approaches to controlling malaria. Parasitol Today 13(3):125-, author reply 125-126.
33. Smith DL, Hay SI, Noor AM, Snow RW (2009) Predicting changing malaria risk after expanded insecticide-treated net coverage in Africa. Trends Parasitol 25(11):511-516.
34. Hay SI, et al. (2010) Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med 7(6):e1000290.
35. Snow RW, Craig M, Deichmann U, Marsh K (1999) Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ 77(8):624-640.
36. Vos T, et al. (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2163-2196.
37. World Health Organization (WHO) Roll Back Malaria Partnership (2008) The Global Malaria Action Plan for a Malaria-Free World. Available at www.rbm.who.int/gmap/index.html.
38. Feachem RG, et al. (2010) Shrinking the malaria map: Progress and prospects. Lancet 376(9752):1566-1578.
39. Liu J, Modrek S, Gosling RD, Feachem RG (2013) Malaria eradication: Is it possible? Is it worth it? Should we do it? Lancet Glob Health 1(1):e2-e3.
40. Snow RW, et al. (1998) Risk of severe malaria among African infants: Direct evidence of clinical protection during early infancy. J Infect Dis 177(3):819-822.
41. Kleinschmidt I, et al. (2009) Marked increase in child survival after four years of intensive malaria control. Am J Trop Med Hyg 80(6):882-888.
42. Alonso PL, et al. (1993) A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, West Africa. 5. Design and implementation of the trial. Trans R Soc Trop Med Hyg 87(Suppl 2):31-36.
43. D'Alessandro U, et al. (1995) Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme. Lancet 345(8948):479-483.
44. Phillips-Howard PA, et al. (2003) Efficacy of permethrin-treated bed nets in the prevention of mortality in young children in an area of high perennial malaria transmission in western Kenya. Am J Trop Med Hyg 68(4, Suppl):23-29.
45. O'Meara WP, et al. (2008) Relationship between exposure, clinical malaria, and age in an area of changing transmission intensity. Am J Trop Med Hyg 79(2):185-191.
46. Chiyaka C, et al. (2013) Infectious disease. The stability of malaria elimination. Science 339(6122):909-910.
47. Doolan DL, Dobaño C, Baird JK (2009) Acquired immunity to malaria. Clin Microbiol Rev 22(1):13-36.
48. Woolhouse ME (1998) Patterns in parasite epidemiology: The peak shift. Parasitol Today 14(10):428-434.
49. Carneiro I, et al. (2010) Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: A systematic review and pooled analysis. PLoS ONE 5(2):e8988.
50. Mharakurwa S, et al.; Southern Africa ICEMR Team (2013) Changes in the burden of malaria following scale up of malaria control interventions in Mutasa District, Zimbabwe. Malar J 12:223.
51. O'Meara WP, et al. (2008) Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet 372(9649):1555-1562.
52. Snow RW, Marsh K (2002) The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv Parasitol 52:235-264.
53. Trape JF, et al. (2011) Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: A longitudinal study. Lancet Infect Dis 11(12):925-932.
54. Trape JF, Rogier C (1996) Combating malaria morbidity and mortality by reducing transmission. Parasitol Today 12(6):236-240.
55. Lengeler C, Smith TA, Armstrong Schellenberg J (1997) Focus on the effect of bednets on malaria morbidity and mortality. Parasitol Today 13(3):123-124, author reply 125-126.
56. D'Alessandro U, Coosemans M (1997) Concerns on long-term efficacy of an insecticide-treated bednet programme on child mortality. Parasitol Today 13(3):124-125, author reply 125-126.
57. Keating J, Eisele TP (2011) Epidemiology of malaria morbidity after control scale-up. Lancet Infect Dis 11(12):891-892.
58. Cotter C, et al. (2013) The changing epidemiology of malaria elimination: New strategies for new challenges. Lancet 382(9895):900-911.
59. Murray CJ, et al. (2012) Global malaria mortality between 1980 and 2010: A systematic analysis. Lancet 379(9814):413-431.
60. Masquelier B, Reniers G, Pison G (2013) Divergences in trends in child and adult mortality in sub-Saharan Africa: Survey evidence on the survival of children and siblings. Popul Stud 68(2):161-177.
61. Smith T, Schapira A (2012) Reproduction numbers in malaria and their implications. Trends Parasitol 28(1):3-8.
62. Murray CJ (1994) Quantifying the burden of disease: The technical basis for disability-adjusted life years. Bull World Health Org 72(3):429-445.
63. Chen DS, et al. (2011) A molecular epidemiological study of var gene diversity to characterize the reservoir of Plasmodium falciparum in humans in Africa. PLoS ONE 6(2):e16629.
64. Artzy-Randrup Y, et al. (2012) Population structuring of multi-copy, antigen-encoding genes in Plasmodium falciparum. eLife 1:e00093.
65. Gandon S, Mackinnon MJ, Nee S, Read AF (2001) Imperfect vaccines and the evolution of pathogen virulence. Nature 414(6865):751-756.
66. Okiro EA, et al. (2009) Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity. Malar J 8:4.
67. Fowkes FJ, et al. (2012) New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women. J Infect Dis 206(10):1612-1621.
68. Holling CS (1959) The components of predation as revealed by a study of small-mammal predation of the European pine sawfly. Can Entomol 91(5):293-320.
69. Russell TL, et al. (2011) Increased proportions of outdoor feeding among residual malaria vector populations following increased use of insecticide-treated nets in rural Tanzania. Malar J 10:80.
70. Moore SJ, Davies CR, Hill N, Cameron MM (2007) Are mosquitoes diverted from repellent-using individuals to non-users? Results of a field study in Bolivia. Trop Med Int Health 12(4):532-539.
71. Ferguson HM, et al. (2010) Ecology: A prerequisite for malaria elimination and eradication. PLoS Med 7(8):e1000303.
72. Russell TL, Beebe NW, Cooper RD, Lobo NF, Burkot TR (2013) Successful malaria elimination strategies require interventions that target changing vector behaviours. Malar J 12:56.
73. Anderson RM, May RM (1991) Infectious Diseases of Humans: Dynamics and Control (Oxford Univ Press, New York).
74. Dobson A, Foufopoulos J (2001) Emerging infectious pathogens of wildlife. Philos Trans R Soc Lond B Biol Sci 356(1411):1001-1012.
75. Richards JS, Beeson JG (2009) The future for blood-stage vaccines against malaria. Immunol Cell Biol 87(5):377-390.